Surgical oncology and reconstructionSurgical Treatment, Oral Rehabilitation, and Orthognathic Surgery After Failure of Pharmacologic Treatment of Central Giant Cell Lesion: A Case Report
Section snippets
Case Report
In July 2003, a 20-year-old female patient presented to the oral and maxillofacial surgery department with complaints of painful swelling in the mandible with rapid growth. Her medical and family histories were noncontributory. The extraoral clinical examination revealed considerable swelling in the region of the symphysis and left mandibular body. No associated lymphadenopathy was present. The intraoral clinical examination revealed an obliteration of the buccal sulcus, elevation of the floor
Discussion
Nonsurgical methods for the treatment of CGCL are of great importance, mainly because the prevalence of this lesion is greater in young people and the treatment can alter the development of the jaws and cause important aesthetic disfigurations. These treatments can achieve complete resolution of the lesion; however, in some cases, a bone defect can persist, requiring bone osteoplasty. In cases of partial resolution of the lesion, surgical curettage is usually used as the additional treatment.5
References (20)
- et al.
Central giant cell granuloma of the jaws: A clinical, radiologic, and histopathologic study of 26 cases
Oral Surg Oral Med Oral Pathol Oral Radiol Endod
(2006) - et al.
Central giant cell lesions of the jaws: A clinicopathologic study
J Oral Maxillofac Surg
(1986) - et al.
Central giant cell reparative granuloma of the mandible caused by a molar tooth extraction: Special reference to the manuever of drilling the surgical field
Int J Pediatr Otorhinolaryngol
(2006) - et al.
Treatment of giant cell granuloma with calcitonin
Int J Oral Maxillofac Surg
(1999) - et al.
Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant-cell granuloma in 21 cases
Int J Oral Maxillofac Surg
(2010) - et al.
Adjuvant antiangiogenic therapy for giant cell tumors of the jaws
J Oral Maxillofac Surg
(2007) - et al.
Antiangiogenic therapy with interferon alpha for giant cell lesions of the jaws
J Oral Maxillofac Surg
(2002) - et al.
Management of central giant cell granuloma with subcutaneous denosumab therapy
J Oral Maxillofac Surg
(2014) - et al.
Alternative pharmacologic therapy for aggressive central giant cell granuloma: Denosumab
J Oral Maxillofac Surg
(2014) - et al.
Aggressive giant cell lesion of the jaws: A review of management options and report of a mandibular lesion treated with denosumab
Oral Surg Oral Med Oral Pathol Oral Radiol
(2015)
Cited by (3)
Intralesional injection of triamcinolone hexacetonide as an alternative treatment for central giant cell lesions: a prospective study
2020, British Journal of Oral and Maxillofacial SurgeryCitation Excerpt :Several treatments have been proposed for CGCL. Traditionally, a surgical treatment is adopted, ranging from simple curettage to aggressive en-bloc resection, with variations in recurrence rates (up to 37.2%)5 often leading to loss of teeth or even facial disfiguration, which may require multiple steps of rehabilitation.20 Non-surgical treatments can achieve complete resolution of the lesion or a significant reduction in size, allowing for a less-aggressive surgical treatment.
Central giant cell granuloma mimicking a periapical lesion of endodontic origin: A case report
2020, Australian Endodontic JournalIntra-lesional medicaments for the management of intra-osseous lesions of maxilla and mandible - systematic review
2020, Journal of International Society of Preventive and Community Dentistry